Airway Management Devices Market: Current Analysis and Forecast (2021-2027)

Airway management comprises set of medical procedures to prevent airway obstruction in patients. This device safeguards an open pathway in patients that allows the gas exchange between a patient's lungs and the atmosphere. There are various products such as oropharyngeal airway, nasopharyngeal airways, laryngeal mask airways and tracheal incubation used in providing airway in patients who are undergoing anesthesia procedures in hospitals. These devices are found to be used in fields of anesthesia, cardiopulmonary resuscitation, emergency medicine, neonatology, and many others. In neonatology it has application for managing airway among babies and increasing incidence of preterm birth may require the need of airway management. For instance, according to World Health Organization, stated in 2018, approximately 15 million preterm babies are born each year (before 37 weeks of gestation), which is more than 1 out of 10 infants and this number is increasing per year. In 184 nations, preterm birth rates vary from 5% to 18% of infants born. Increase in preterm birth worldwide is one of the major factors in driving the market.
Based on type the global Airway Management Devices Market is segmented into Infraglottic Airway Management Devices, Supraglottic Airway Management Devices, Laryngoscopes, Resuscitators, and Others. Currently, Infraglottic devices segment is expected to dominate the market by holding largest market share during the forecast period. Surging demand for positive air pressure ventilation among the patients facing respiratory failure is driving the demand for intubation, thereby contributing to the growth of this segment. The Infraglottic devices such as endotracheal tubes and tracheostomy tubes are used during intubation for rescuing airway and provide ventilation after connecting with external breathing assistance systems.
In terms of application, the market is grouped into Anesthesia, Emergency Medicine and Others. Among them, the anesthesia segment is forecasted to lead the market share during the forecast period. This can be ascribed to the increasing growth in the number of surgical interventions globally, that require the patients to be provided with anesthesia.
By patient age, the global Airway Management Devices Market is segmented into Adult Patients and Pediatric/Neonatal Patients. Adult segment is dominating the market. The growing adult population and the increase in the occurrence of chronic diseases in geriatric patients are the key factors contributing for the of adult patients age segment. According to the Centers for Disease Control and Prevention (CDC), in 2015, total number of the emergency department visit with the chronic diseases in the U.S. are Chronic obstructive pulmonary disease (COPD) 7,251, Congestive heart failure 4,413 Hypertension 32,370 per thousand patients.
Based on end-user the market is categorized into Hospitals, Ambulatory Care Settings, Home Care Settings and Others. At present, hospital segment dominates the market and is expected to maintain its dominance during the analyzed period as well. This supremacy is ascribed to growing rising number of hospitals and infrastructural & economic development, especially in emerging countries. In addition to this, increase in surgical procedures performed-where airway management devices are used for ventilation, oxygenation, and the administration of anesthesia-also supports high growth in the hospitals segment.
For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), and Rest of World. North America has dominated the Airway Management Devices market which is attributable to the presence of a highly developed healthcare system, the increasing number of healthcare settings, the rising prevalence of chronic respiratory diseases, significant number of prominent vendors, and favorable reimbursement policies for airway management devices.
Moreover, Asia Pacific region is anticipated to witness highest growth over the next 5 years on account of presence of high-growth markets such as India, China, and Japan; rapid growth in the geriatric population; increasing demand for critical care units; the implementation of favorable government initiatives; growing per capita income; increasing investments in the healthcare industry; the rising demand for cutting-edge technologies; and the expansion of private-sector hospitals to rural areas.
In addition, the Asia Pacific is becoming a medical tourism hub and is considered one of the fastest-growing markets for medical procedures and devices. Low infrastructure and treatment costs and the availability of highly educated physicians have driven medical tourists to APAC countries, particularly to India, Malaysia, and China. Furthermore, high R&D investment by the global players and the presence of unexplored opportunities in this region serve as high growth rendering drivers.
Some of the major players operating in the market include Medtronic Plc, Smiths Medical (Smiths Group Plc), Teleflex Inc, Ambu A/S, Convatec Group, Karl Storz Se & Co. Kg, Flexicare, Intersurgical, Sunmed and Vyaire Medical Inc.

Frequently Asked Questions